<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cancer survival</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Cancer care costs higher in U.S. than Europe, but survival longer</title>
   	 <description>(HealthDay) -- The United States spends more on health care than any other country, but those high costs may be paying off in cancer survival, a new report suggests.</description>
     <link>http://medicalxpress.com/news/2012-04-cancer-higher-europe-survival-longer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 Apr 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news253207469</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cancercareco.jpg" width="90" height="90" />
</item>
<item>
     <title>Lung cancer screening might pay off, analysis shows</title>
   	 <description>(HealthDay) -- Screening people at high risk for lung cancer could be at least as cost-effective as screening for breast, colorectal and cervical cancers, a new study suggests.</description>
     <link>http://medicalxpress.com/news/2012-04-lung-cancer-screening-analysis.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 Apr 2012 16:40:01 EST</pubDate>
	 <guid isPermaLink="false">news253207319</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lungcancersc.jpg" width="90" height="90" />
</item>
<item>
     <title>Womb cancer deaths rise by a fifth in the last decade</title>
   	 <description>(Medical Xpress) -- Deaths from womb (uterine) cancer have risen by nearly twenty per cent in the last decade, according to new figures from Cancer Research UK today.</description>
     <link>http://medicalxpress.com/news/2012-04-womb-cancer-deaths-decade.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 Apr 2012 08:24:28 EST</pubDate>
	 <guid isPermaLink="false">news252833049</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/wombcancerde.gif" width="90" height="90" />
</item>
<item>
     <title>Researchers develop a new cell and animal model of inflammatory breast cancer</title>
   	 <description>Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent&amp;#151;significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that IBC usually grows rapidly and often spreads quickly to other parts of the body, including the brain, bone and lymph nodes. In an effort to better understand the biology of IBC, researchers at Fox Chase Cancer Center have developed a new cell and animal model that holds promise for providing a detailed understanding of the molecular mechanisms underlying the disease and for developing effective interventions.</description>
     <link>http://medicalxpress.com/news/2012-04-cell-animal-inflammatory-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Apr 2012 09:45:08 EST</pubDate>
	 <guid isPermaLink="false">news252751500</guid>
	 
</item>
<item>
     <title>Baseline hormone levels may predict survival in metastatic, castration-resistant prostate cancer</title>
   	 <description>Patients with castration-resistant prostate cancer treated with the androgen inhibitor abiraterone and who had high baseline hormone levels had longer overall survival compared with patients with low hormone levels, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.</description>
     <link>http://medicalxpress.com/news/2012-04-baseline-hormone-survival-metastatic-castration-resistant.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 17:40:45 EST</pubDate>
	 <guid isPermaLink="false">news252693639</guid>
	 
</item>
<item>
     <title>Cruciferous vegetable consumption linked to improved breast cancer survival rates</title>
   	 <description>Eating cruciferous vegetables after breast cancer diagnosis was associated with improved survival among Chinese women, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4.</description>
     <link>http://medicalxpress.com/news/2012-04-cruciferous-vegetable-consumption-linked-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 15:04:53 EST</pubDate>
	 <guid isPermaLink="false">news252684284</guid>
	 
</item>
<item>
     <title>Does BMI affect post-surgical complications, survival in esophageal adenocarcinoma?</title>
   	 <description>Researchers at Moffitt Cancer Center in Tampa, Fla., have found &amp;#150; contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) &amp;#150; that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.</description>
     <link>http://medicalxpress.com/news/2012-03-bmi-affect-post-surgical-complications-survival.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 28 Mar 2012 11:49:45 EST</pubDate>
	 <guid isPermaLink="false">news252154172</guid>
	 
</item>
<item>
     <title>Black women, uninsured get worse ovarian cancer care: study</title>
   	 <description>(HealthDay) -- Women with ovarian cancer who are black, either uninsured or Medicare recipients, or who have annual incomes of less than $35,000 are more likely to receive poorer-quality care, a new study shows.</description>
     <link>http://medicalxpress.com/news/2012-03-black-women-uninsured-worse-ovarian.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 27 Mar 2012 15:31:48 EST</pubDate>
	 <guid isPermaLink="false">news252081099</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/blackwomenun.jpg" width="90" height="90" />
</item>
<item>
     <title>&amp;#1057;ancer survival study uncovers wide racial disparities</title>
   	 <description>African Americans in Georgia, especially in rural areas, have drastically poorer survival rates from cancer. These disparities are much larger when compared to national data, according to the findings from a study recently published in the journal Cancer by a team of researchers in the University of Georgia College of Public Health.</description>
     <link>http://medicalxpress.com/news/2012-03-1057ancer-survival-uncovers-wide-racial.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 13 Mar 2012 16:15:18 EST</pubDate>
	 <guid isPermaLink="false">news250874113</guid>
	 
</item>
<item>
     <title>Study finds association between genetic mutation and age at diagnosis for common childhood cancer</title>
   	 <description>Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system, according to a study in the March 14 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-03-association-genetic-mutation-age-diagnosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 13 Mar 2012 16:00:04 EST</pubDate>
	 <guid isPermaLink="false">news250869158</guid>
	 
</item>
<item>
     <title>Study reports steady increases in long-term survival among children with acute lymphoblastic leukemia</title>
   	 <description>A study by the Children's Oncology Group (COG) reported that five-year survival for acute lymphoblastic leukemia (ALL, the most common type of pediatric cancer) among children treated through COG clinical trials increased from 83.7 percent during the period 1990-1994 to 90.4 percent in the period 2000-2005. The improvements in survival were observed among all children over age 1 regardless of age, sex, ethnicity, or subtype of ALL. This analysis, which is the largest study to date of ALL survival, showed similar gains in 10-year survival. The findings are published March 12 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-03-steady-long-term-survival-children-acute.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Mar 2012 16:00:09 EST</pubDate>
	 <guid isPermaLink="false">news250779264</guid>
	 
</item>
<item>
     <title>More people surviving cancer in Northern Ireland</title>
   	 <description>Despite the rising incidence of cancer in Northern Ireland, the number of people surviving the disease in the country is increasing significantly year on year.</description>
     <link>http://medicalxpress.com/news/2012-02-people-surviving-cancer-northern-ireland.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 28 Feb 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news249652069</guid>
	 
</item>
<item>
     <title>Choosing the best breast cancer treatment option</title>
   	 <description>According to published reports from the Institute of Medicine and the New England Journal of Medicine, roughly one-third of early-stage breast cancer patients undergo mastectomy even though breast conservation surgery with radiation therapy results in equal survival rates. </description>
     <link>http://medicalxpress.com/news/2012-02-breast-cancer-treatment-option.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 20 Feb 2012 06:20:21 EST</pubDate>
	 <guid isPermaLink="false">news248941211</guid>
	 
</item>
<item>
     <title>Study proves targeted tumor freezing therapy increases ovarian cancer survival</title>
   	 <description>Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.</description>
     <link>http://medicalxpress.com/news/2012-02-tumor-therapy-ovarian-cancer-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Feb 2012 15:32:22 EST</pubDate>
	 <guid isPermaLink="false">news248628735</guid>
	 
</item>
<item>
     <title>Younger breast cancer patients have more adverse quality-of-life issues</title>
   	 <description>Younger women with breast cancer experience a decrease in their health-related quality of life (QOL), associated with increased psychological distress, weight gain, a decline in their physical activity, infertility and early onset menopause, according to a study published January 20 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-01-younger-breast-cancer-patients-adverse.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 20 Jan 2012 17:55:06 EST</pubDate>
	 <guid isPermaLink="false">news246304499</guid>
	 
</item>
<item>
     <title>Personalized gene therapies may increase survival in brain cancer patients</title>
   	 <description>Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois study funded by the NIH National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-01-personalized-gene-therapies-survival-brain.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 Jan 2012 11:40:03 EST</pubDate>
	 <guid isPermaLink="false">news245330965</guid>
	 
</item>
<item>
     <title>Scientists find genetic key to why some cancer patients don't respond to treatment</title>
   	 <description>(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.</description>
     <link>http://medicalxpress.com/news/2012-01-scientists-genetic-key-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 Jan 2012 09:20:01 EST</pubDate>
	 <guid isPermaLink="false">news244976719</guid>
	 
</item>
<item>
     <title>Simple test to help diagnose bowel and pancreatic cancer could save thousands of lives</title>
   	 <description>A simple online calculator could offer family GPs a powerful new tool in tackling two of the most deadly forms of cancer, say researchers.</description>
     <link>http://medicalxpress.com/news/2011-12-simple-bowel-pancreatic-cancer-thousands.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Dec 2011 09:49:43 EST</pubDate>
	 <guid isPermaLink="false">news243078563</guid>
	 
</item>
<item>
     <title>Improvements in survival of gynecological cancer in the Anglia region of England</title>
   	 <description>Gynaecological cancer survival rates have improved in Eastern England following the reorganisation of services and multidisciplinary team working finds a new study published today (14 December) in the gynaecological oncology themed issue of BJOG: An International Journal of Obstetrics and Gynaecology.</description>
     <link>http://medicalxpress.com/news/2011-12-survival-gynecological-cancer-anglia-region.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Dec 2011 04:40:01 EST</pubDate>
	 <guid isPermaLink="false">news243059035</guid>
	 
</item>
<item>
     <title>Anti-estrogen combo better than single drug for hormone-sensitive breast cancer</title>
   	 <description>Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.</description>
     <link>http://medicalxpress.com/news/2011-12-anti-estrogen-combo-drug-hormone-sensitive-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 07 Dec 2011 10:26:21 EST</pubDate>
	 <guid isPermaLink="false">news242475965</guid>
	 
</item>
<item>
     <title>Internal skin cancer prevention: Repairing UV damage in the skin</title>
   	 <description>(Medical Xpress) -- Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) of the Novartis Research Foundation have elucidated the mechanisms underlying the repair of UV-induced damage in DNA, which frequently causes skin cancer. The protein structures additionally determined by these researchers will improve our understanding of how the body protects itself against skin cancer. These studies lay the foundations for the development of a new class of anti cancer agents. The findings were published today in Cell.</description>
     <link>http://medicalxpress.com/news/2011-11-internal-skin-cancer-uv.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 Nov 2011 07:55:16 EST</pubDate>
	 <guid isPermaLink="false">news241343677</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/internalskin.jpg" width="90" height="90" />
</item>
<item>
     <title>Discovery may help fight late-stage ovarian cancer</title>
   	 <description>A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often undetected disease.</description>
     <link>http://medicalxpress.com/news/2011-11-discovery-late-stage-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 16 Nov 2011 11:00:03 EST</pubDate>
	 <guid isPermaLink="false">news240662556</guid>
	 
</item>
<item>
     <title>More radionuclide therapy is better for prostate cancer patients</title>
   	 <description>For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November issue of The Journal of Nuclear Medicine.</description>
     <link>http://medicalxpress.com/news/2011-11-radionuclide-therapy-prostate-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 01 Nov 2011 10:21:45 EST</pubDate>
	 <guid isPermaLink="false">news239361694</guid>
	 
</item>
<item>
     <title>Turning up the heat to kill cancer cells: The 'Lance Armstrong effect'</title>
   	 <description>The &quot;Lance Armstrong effect&quot; could become a powerful new weapon to fight cancer cells that develop resistance to chemotherapy, radiation and other treatments, scientists say in a report in the ACS journal Molecular Pharmaceutics.</description>
     <link>http://medicalxpress.com/news/2011-10-cancer-cells-lance-armstrong-effect.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 19 Oct 2011 13:14:46 EST</pubDate>
	 <guid isPermaLink="false">news238248878</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/turningupthe.gif" width="90" height="90" />
</item>
<item>
     <title>'Never married' men still more likely to die from cancer</title>
   	 <description>It is known that the unmarried are in general more likely to die than their married counterparts and there is some indication that the divide is in fact getting worse. New research published in BioMed Central's open access journal BMC Public Health looks at the changes in cancer survival over the past 40 years and show that the difference in mortality between the married and never married, especially between married and never married men, has also increased.</description>
     <link>http://medicalxpress.com/news/2011-10-men-die-cancer.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 14 Oct 2011 04:26:24 EST</pubDate>
	 <guid isPermaLink="false">news237785068</guid>
	 
</item>
<item>
     <title>Survival disparities in African-American and white colo-rectal cancer patients</title>
   	 <description>African-American patients with resected stage II and stage III colon cancer experienced worse overall and recurrence-free survival compared to whites, but similar recurrence-free intervals, according to a study published Oct. 12 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-10-survival-disparities-african-american-white-colo-rectal.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 12 Oct 2011 16:40:44 EST</pubDate>
	 <guid isPermaLink="false">news237656433</guid>
	 
</item>
<item>
     <title>Poor people more likely to view cancer as fatal</title>
   	 <description>(Medical Xpress) -- People in lower paid jobs are pessimistic about the benefits of diagnosing cancer early and more scared than affluent people to see a doctor about an unusual symptom, new research shows.</description>
     <link>http://medicalxpress.com/news/2011-10-poor-people-view-cancer-fatal.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 10 Oct 2011 09:26:17 EST</pubDate>
	 <guid isPermaLink="false">news237457566</guid>
	 
</item>
<item>
     <title>Survival increased in early stage breast cancer after treatment with herceptin and chemo</title>
   	 <description>Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday.</description>
     <link>http://medicalxpress.com/news/2011-10-survival-early-stage-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 05 Oct 2011 17:54:07 EST</pubDate>
	 <guid isPermaLink="false">news237056037</guid>
	 
</item>
<item>
     <title>Smaller, faster trials can improve cancer patient survival</title>
   	 <description>With the advent of personalised medicine, gains in cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, a researcher told the 2011 European Multidisciplinary Cancer Congress today (Monday 26 Sept).</description>
     <link>http://medicalxpress.com/news/2011-09-smaller-faster-trials-cancer-patient.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Sep 2011 04:35:36 EST</pubDate>
	 <guid isPermaLink="false">news236230524</guid>
	 
</item>
<item>
     <title>Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years</title>
   	 <description>Stockholm, Sweden: Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-09-aromatase-inhibitor-letrozole-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 25 Sep 2011 13:13:58 EST</pubDate>
	 <guid isPermaLink="false">news236175212</guid>
	 
</item>


</channel>
</rss>
